Vaderis Therapeutics
Latest round
- Series B
Last raised
- Aug 2026
Total raised
- $152M
Investors
- 8
About Vaderis Therapeutics
Based in Basel, Switzerland, Vaderis Therapeutics AG operates as a clinical-stage biopharmaceutical company developing targeted therapies for rare vascular diseases, founded in 2019 by Nicholas Benedict, Pierre Saint-Mezard, and Damien Picard.
Who invested in Vaderis Therapeutics
8 investors across 1 round
See all investors in Vaderis Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 11, 2026
Amount
$152M
Investors
Questions about Vaderis Therapeutics
Who invested in Vaderis Therapeutics?
Vaderis Therapeutics has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vaderis Therapeutics raised?
Vaderis Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Vaderis Therapeutics last raise money?
Vaderis Therapeutics's most recent round on record is a Series B, in Aug 2026.
What does Vaderis Therapeutics do?
Based in Basel, Switzerland, Vaderis Therapeutics AG operates as a clinical-stage biopharmaceutical company developing targeted therapies for rare vascular diseases, founded in 2019 by Nicholas Benedict, Pierre Saint-Mezard, and Damien Picard.
Where is Vaderis Therapeutics headquartered?
Vaderis Therapeutics is headquartered in Basel, Switzerland.
Which VCs invest in companies like Vaderis Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Vaderis Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Vaderis Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.